EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSFHEG00000008398
Gene Symbol: KIF5B
4 Cross references
243 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSFHEG00000009526
Gene Symbol: LTA4H
3 Cross references
205 Possible Orthologues:

Leukotriene B4 Receptor 1

Ensembl ID : ENSFHEG00000010589
Gene Symbol: LOC105917689
3 Cross references
143 Possible Orthologues:

Leukotriene B4 Receptor 1

Ensembl ID : ENSFHEG00000010595
Gene Symbol: LOC105917690
3 Cross references
159 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSFHEG00000000820
Gene Symbol: LOC105916722
3 Cross references
167 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor-Like

Ensembl ID : ENSFHEG00000020704
Gene Symbol: LOC105933778
4 Cross references
201 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSFHEG00000012094
Gene Symbol: KDM1A
3 Cross references
214 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSFHEG00000022797
Gene Symbol: LOXL2
3 Cross references
213 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSFHEG00000003829
Gene Symbol: LOXL2A
1 Cross references
209 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 2

Ensembl ID : ENSFHEG00000003735
Gene Symbol: LOC105918495
2 Cross references
199 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSFHEG00000014428
Gene Symbol: MIF
2 Cross references
235 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSFHEG00000019818
Gene Symbol: MST1R
2 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).